Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1165 |
---|---|
Product Name | Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody |
Molecular Name | Pagibaximab |
Alias | Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab |
CAS Number | 595566-61-3 |
Target | Lipoteichoic Acid[Staphylococcus epidermidis] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | FuncS, IF, Neut, ELISA, FCM, IP |
Buffer | PBS, pH7.5 |
Background | Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |